Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 … C Allemani, T Matsuda, V Di Carlo, R Harewood, M Matz, M Nikšić, ... The Lancet 391 (10125), 1023-1075, 2018 | 4676 | 2018 |
Metastatic behavior of breast cancer subtypes H Kennecke, R Yerushalmi, R Woods, MCU Cheang, D Voduc, ... Journal of clinical oncology 28 (20), 3271-3277, 2010 | 2666 | 2010 |
International incidence of childhood cancer, 2001–10: a population-based registry study E Steliarova-Foucher, M Colombet, LAG Ries, F Moreno, A Dolya, F Bray, ... The Lancet Oncology 18 (6), 719-731, 2017 | 1816 | 2017 |
Ki67 in breast cancer: prognostic and predictive potential R Yerushalmi, R Woods, PM Ravdin, MM Hayes, KA Gelmon The lancet oncology 11 (2), 174-183, 2010 | 1573 | 2010 |
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study M Arnold, MJ Rutherford, A Bardot, J Ferlay, TML Andersson, ... The Lancet Oncology 20 (11), 1493-1505, 2019 | 914 | 2019 |
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival NA Johnson, KJ Savage, O Ludkovski, S Ben-Neriah, R Woods, C Steidl, ... Blood, The Journal of the American Society of Hematology 114 (11), 2273-2279, 2009 | 733 | 2009 |
Projected estimates of cancer in Canada in 2020 DR Brenner, HK Weir, AA Demers, LF Ellison, C Louzado, A Shaw, ... Cmaj 192 (9), E199-E205, 2020 | 535 | 2020 |
Changes in colorectal cancer incidence in seven high-income countries: a population-based study M Araghi, I Soerjomataram, A Bardot, J Ferlay, CJ Cabasag, DS Morrison, ... The lancet Gastroenterology & hepatology 4 (7), 511-518, 2019 | 392 | 2019 |
Projected estimates of cancer in Canada in 2022 DR Brenner, A Poirier, RR Woods, LF Ellison, JM Billette, AA Demers, ... Cmaj 194 (17), E601-E607, 2022 | 251 | 2022 |
Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children … A Bonaventure, R Harewood, CA Stiller, G Gatta, J Clavel, DC Stefan, ... The Lancet Haematology 4 (5), e202-e217, 2017 | 222 | 2017 |
Adjuvant chemotherapy use and outcomes of patients with high‐risk versus low‐risk stage II colon cancer A Kumar, HF Kennecke, DJ Renouf, HJ Lim, S Gill, R Woods, C Speers, ... Cancer 121 (4), 527-534, 2015 | 165 | 2015 |
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2) M Matz, MP Coleman, M Sant, MD Chirlaque, O Visser, M Gore, ... Gynecologic oncology 144 (2), 405-413, 2017 | 141 | 2017 |
Long‐term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy BA Campbell, N Voss, R Woods, RD Gascoyne, J Morris, T Pickles, ... Cancer 116 (16), 3797-3806, 2010 | 139 | 2010 |
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2) M Matz, MP Coleman, H Carreira, D Salmerón, MD Chirlaque, C Allemani, ... Gynecologic oncology 144 (2), 396-404, 2017 | 138 | 2017 |
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome R Yerushalmi, S Tyldesley, H Kennecke, C Speers, R Woods, B Knight, ... Annals of oncology 23 (2), 338-345, 2012 | 134 | 2012 |
The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2 ME Baser, L Kuramoto, R Woods, H Joe, JM Friedman, AJ Wallace, ... Journal of medical genetics 42 (7), 540-546, 2005 | 132 | 2005 |
Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence R Yerushalmi, H Kennecke, R Woods, IA Olivotto, C Speers, KA Gelmon Breast cancer research and treatment 117, 365-370, 2009 | 104 | 2009 |
Colon and rectal cancer survival in seven high-income countries 2010–2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project) M Araghi, M Arnold, MJ Rutherford, MG Guren, CJ Cabasag, A Bardot, ... Gut 70 (1), 114-126, 2021 | 103 | 2021 |
Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada NZ Janjua, M Chong, M Kuo, R Woods, J Wong, EM Yoshida, M Sherman, ... Journal of hepatology 66 (3), 504-513, 2017 | 102 | 2017 |
Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality? R Yerushalmi, S Tyldesley, R Woods, HF Kennecke, C Speers, ... Annals of oncology 23 (4), 876-881, 2012 | 79 | 2012 |